Table 3 Sensitivity analysis for correlation of Ang-2 expression and survival of NSCLC patients
From: Prognostic value of angiopoietin-2 in non-small cell lung cancer patients: a meta-analysis
Study omitted | Resulting HR (95Â % CI) |
|---|---|
None | 1.93 (1.47–2.52) |
Andersen 2011 | 1.95 (1.41–2.69) |
Park 2007 | 1.92 (1.40–2.62) |
Massabeau 2008 | 1.97 (1.47–2.63) |
Coelho 2014 | 1.90 (1.40–2.57) |
Daly 2014 | 1.91 (1.44–2.53) |